137 related articles for article (PubMed ID: 28985230)
1. Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo.
Zhu Q; Pan X; Sun Y; Wang Z; Liu F; Li A; Zhao Z; Wang Y; Li K; Mi L
PLoS One; 2017; 12(10):e0185507. PubMed ID: 28985230
[TBL] [Abstract][Full Text] [Related]
2. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
3. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
4. Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
Yalcin M; Lin HY; Sudha T; Bharali DJ; Meng R; Tang HY; Davis FB; Stain SC; Davis PJ; Mousa SA
Horm Cancer; 2013 Jun; 4(3):176-85. PubMed ID: 23456390
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
6. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
Qiu C; Bu X; Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
Long J; Liu Z; Hui L
BMC Complement Altern Med; 2019 Jun; 19(1):133. PubMed ID: 31215421
[TBL] [Abstract][Full Text] [Related]
8. Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
Harima H; Kaino S; Takami T; Shinoda S; Matsumoto T; Fujisawa K; Yamamoto N; Yamasaki T; Sakaida I
BMC Cancer; 2016 Aug; 16(1):702. PubMed ID: 27582255
[TBL] [Abstract][Full Text] [Related]
9. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
[TBL] [Abstract][Full Text] [Related]
10. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
11. [Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].
Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):739-45. PubMed ID: 27371838
[TBL] [Abstract][Full Text] [Related]
12. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
Zhu H; Qin H; Li DM; Liu J; Zhao Q
Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
14. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
[TBL] [Abstract][Full Text] [Related]
15. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
16. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
17. Induction of CTLs by DCs pulsed with K-ras mutant peptide on the surface of nanoparticles in the treatment of pancreatic cancer.
Tan G; Wang Z; Zhang X; Cai Z; Zhang J
Oncol Rep; 2011 Jul; 26(1):215-21. PubMed ID: 21573499
[TBL] [Abstract][Full Text] [Related]
18. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
19. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
